Motif FoodWorks, launched by Gingko Bioworks, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Gingko agreed to a reverse merger.

SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.

Propel Venture Partners has helped the retirement plan provider increase its overall funding to $344m by investing in a round led by General Atlantic.

The Tencent and TAL Education-backed business management platform developer received the capital from IDG Capital, Hillhouse Capital, GGV Capital and Qiming Venture Partners.

The CreditEase-backed wealth management software provider was valued at $2bn after securing investment from D1 Capital Partners.

Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute, has picked up a series B co-led by SoftBank Vision Fund 2.

Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.

The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.

The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.

The CSP technology developer revealed two new funding rounds including an $83m bridge round backed by ArcelorMittal and Edison International.